跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HUMALOG U200 KwikPen insulin lispro (rbe) 200 IU/mL solution for injection multidose syringe - TGA Drug Approval Details
Approvals
/
TGA
/
HUMALOG U200 KwikPen insulin lispro (rbe) 200 IU/mL solution for injection multidose syringe
Approved
STANDARD
HUMALOG U200 KwikPen insulin lispro (rbe) 200 IU/mL solution for injection multidose syringe
Eli Lilly Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
58c2a58aeedc9817
Company
Eli Lilly Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
58c2a58aeedc9817
Product Name
HUMALOG U200 KwikPen insulin lispro (rbe) 200 IU/mL solution for injection multidose syringe
Artg Id
226893
Artg Name
HUMALOG U200 KwikPen insulin lispro (rbe) 200 IU/mL solution for injection multidose syringe
Sponsor
Eli Lilly Australia Pty Ltd
Company Detail Path
/organization/eli-lilly-australia-pty-ltd
Artg Date
2015-11-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/35ee91c0ba00f811f2642de4990b0a6f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6aee7ea19169127565fa29d1edf313fd.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
58c2a58aeedc9817
Type
Standard
Back to TGA Approvals